Histoindex's Stain-Free Digital Pathology System Receives HSA Approval for Liver Diagnosis

[The Straits Times and Multiple Coverage]

Designed to aid pathologists in the clinical diagnosis of liver fibrosis and other chronic liver diseases, the stain-free Laennec® digital pathology imaging system by MedTech innovator Histoindex Pte. Ltd. has achieved its first regulated in vitro diagnostics (IVD) product status with the issuance of a Health Sciences Authority (HSA) Class A licence. This is a world's first achievement for a stain-free digital pathology innovation to be approved for use in a clinical diagnosis setting.

Click here for the full scoop in The Straits Times.


The press release was featured in:

PR NewsWire


Business Insider

BioSpectrum Asia

Tissue Pathology

Pharma Compass

Healthy Times